Endometrial Metabolism of 17β-Estradiol during the Window of Implantation in Women with Recurrent Implantation Failure
Authors:
- Linda B.P.M Stevens BrentjensLBLinda B.P.M Stevens Brentjens
- Bert DelvouxBDBert Delvoux
- Janneke E. Den HartogJHJanneke E. Den Hartog
- Darina ObukhovaDODarina Obukhova
- Sofia XanthouleaSXSofia Xanthoulea
- Andrea RomanoAndrea Romano
- Ron J.T. van GoldeRGRon J.T. van Golde
Open Access
- 16 May 2025
- journal article
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 91 (2) , 151-162
Abstract
Objectives: Alterations in 17β-estradiol metabolism are known to potentially impair endometrial receptivity. Previous pioneering studies have investigated the role of endometrial steroid metabolism by determining steroid hormone levels and steroid-metabolizing enzyme activity in endometrial biopsies of patients undergoing IVF. The activity of oxidative and reductive 17β-hydroxysteroid dehydrogenases (17β-HSDs), which catalyze the interconversion between estrone and 17β-estradiol, was found to be similar between IVF patients who – after fresh embryo transfer in the cycle following endometrial biopsy – did and did not become pregnant. However, inhibition of the reductive enzyme 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), the most prominent 17β-HSD type in 17β-estradiol formation, was found to differ between groups. The primary objective of this study was to determine oxidative and reductive 17β-HSD enzyme activity in the endometrium of two well-defined groups: IVF patients with recurrent implantation failure (RIF) and control patients. Design: This is a prospective observational study of IVF patients with RIF (n = 52) and controls (n = 25). Patients undergoing treatment because of pre-implantation genetic testing, a severe male factor, or bilateral tubal pathology were recruited as controls since these conditions did not suggest an endometrial contribution to infertility. Participants/Materials, Setting, Methods: Endometrial biopsies were obtained 5–8 days after a positive urine ovulation test in a natural cycle using a Pipelle catheter. Activity of oxidative and reductive enzymes, inhibition of 17β-HSD1, 5, 7, and 12, and immunostaining of 17β-HSD7 were performed. The formation of 17β-estradiol by reduction of estrone (reductive enzymes), formation of estrone by oxidation of 17β-estradiol (oxidative enzymes), and inhibition of specific 17β-HSD enzymes were determined using high-performance liquid chromatography. Formalin-fixed paraffin-embedded tissue was used for immunostaining. The Student’s t test and Mann-Whitney U test were used for statistical analysis. Multivariate analysis was used to determine the influence of confounders. Results: No differences were found in activity of oxidative and reductive 17β-HSD enzymes in RIF patients and controls. Combined inhibition of 17β-HSD5, 7, and 12 was significantly lower in the RIF group compared to controls (p = 0.04). Inhibition of 17β-HSD1 and 17β-HSD7 combined was also significantly lower (more production of 17β-estradiol remained) in the RIF group compared to controls (p < 0.01). However, solely inhibiting 17β-HSD1 or 17β-HSD7 showed no significant difference between groups. Immunostaining revealed the expression of 17β-HSD7 in all endometrial samples. Limitations: Results should be interpreted carefully due to possible cycle-to-cycle variation, challenges to translate in vitro findings to biological conditions, and the heterogeneous etiology of RIF. Conclusions: Differences in formation of 17β-estradiol in the presence of two specific inhibitors of 17β-HSD1 and 7 between RIF patients and controls were found. Although 17β-HSD1, expressed at the fetal-maternal interface, has been associated with fertility, the potential role of 17β-HSD7 in human implantation has not been previously described. The observed differences between patients with RIF and controls warrant future research on the role of this main enzyme and its lesser-known 17β-HSD type in endometrial receptivity and implantation.Keywords
This publication has 33 references indexed in Scilit:
- Prolactin Receptor-Associated Protein/17β-Hydroxysteroid Dehydrogenase Type 7 Gene (Hsd17b7) Plays a Crucial Role in Embryonic Development and Fetal SurvivalMolecular Endocrinology, 2008
- A sensitive HPLC method for the assessment of metabolic conversion of estrogensThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Reproductive biology and IVF: ovarian stimulation and endometrial receptivityTrends in Endocrinology & Metabolism, 2004
- High endometrial aromatase P450 mRNA expression is associated with poor IVF outcomeHuman Reproduction, 2004
- Expression of P450 aromatase and 17β-hydroxysteroid dehydrogenase type 1 at fetal–maternal interface during tubal pregnancyThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantationProceedings of the National Academy of Sciences, 2003
- Human oestrogenic 17β-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reductionBiochemical Journal, 2001
- Expression of Mouse 17β-Hydroxysteroid Dehydrogenase/17-Ketosteroid Reductase Type 7 in the Ovary, Uterus, and Placenta: Localization from Implantation to Late Pregnancy1Endocrinology, 2000
- A prospective randomized trial of blastocyst culture and transfer in in- vitro fertilizationHuman Reproduction, 1998
- Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patientsHuman Genetics, 1997